Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Regional Anesthesia-Lahey Clinic-ankle fracture refers to a specific regional anesthetic intervention evaluated in a clinical trial led by the Lahey Clinic for pain management following operative treatment of ankle fractures. This intervention involves ultrasound-guided nerve blocks of the sciatic and femoral/saphenous nerves using 0.5% ropivacaine (30 mL each). Ropivacaine is a long-acting aminoamide local anesthetic that works by inhibiting sodium channels in nerve fibers, thereby blocking the conduction of nerve impulses and providing regional analgesia. The study compares this regional technique against a long-acting local anesthetic cocktail and traditional standard of care to optimize post-operative recovery and reduce opioid consumption.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Regional Anesthesia-Lahey Clinic-ankle fracture.